PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 26, 2026Infection and Drug Resistance0 citationsOpen Access

A Rare Case of Concurrent Tropheryma Whipplei and Pneumocystis Jirovecii Pneumonia in a Patient During Endocrine Therapy for Breast Cancer

View Full Paper
XLXiaoliang LiQFQi FengHYHailiang Yu

Key Points

  • To highlight a rare case of dual pulmonary infections in a breast cancer patient undergoing endocrine therapy.
  • Case report of a patient receiving endocrine therapy for breast cancer.
  • Diagnosis secured through metagenomic next-generation sequencing of bronchoalveolar lavage fluid.
  • Identified both Tropheryma whipplei and Pneumocystis jirovecii.
  • Patient exhibited concurrent pulmonary infection with Tropheryma whipplei and Pneumocystis jirovecii.
  • Significant clinical and radiological improvement after targeted antimicrobial therapy.

Abstract

Abstract: Tropheryma whipplei (TW), a rare Gram-positive bacterium, is an uncommon cause of pulmonary infection, typically being reported in the context of gastrointestinal or neurological Whipple’s disease. We present a case of a patient receiving endocrine therapy and ovarian suppression for breast cancer who developed a concurrent pulmonary infection with both Pneumocystis jirovecii (PJ) and TW. The diagnosis was secured through metagenomic next-generation sequencing (mNGS) of bronchoalveolar lavage fluid, which successfully identified both pathogens. Following the initiation of targeted antimicrobial therapy, the patient exhibited significant clinical and radiological improvement. Keywords: Tropheryma whipplei, Pneumocystis jirovecii, breast cancer, endocrine therapy, NGS

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Li et al. (2026) studied this question.

synapsesocial.com/papers/699f95951bc9fecf3dab38c5https://doi.org/10.2147/idr.s580235
Ask AI
Helpful
Bookmark
Share
View Full Paper